Published in Circulation on June 04, 2002
Patent foramen ovale in cryptogenic stroke: incidental or pathogenic? Stroke (2009) 4.14
Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2014) 3.48
Transesophageal echocardiography in cryptogenic stroke and patent foramen ovale: analysis of putative high-risk features from the risk of paradoxical embolism database. Circ Cardiovasc Imaging (2013) 2.56
Aortic arch plaques and risk of recurrent stroke and death. Circulation (2009) 2.40
An index to identify stroke-related vs incidental patent foramen ovale in cryptogenic stroke. Neurology (2013) 2.26
Is patent foramen ovale a modifiable risk factor for stroke recurrence? Stroke (2010) 1.83
Patent foramen ovale and migraine: a cross-sectional study from the Northern Manhattan Study (NOMAS). Circulation (2008) 1.77
Patent foramen ovale closure and medical treatments for secondary stroke prevention: a systematic review of observational and randomized evidence. Stroke (2011) 1.74
Patent foramen ovale: anatomy, outcomes, and closure. Nat Rev Cardiol (2011) 1.57
Amyloid mediates the association of apolipoprotein E e4 allele to cognitive function in older people. J Neurol Neurosurg Psychiatry (2005) 1.55
Patent foramen ovale, subclinical cerebrovascular disease, and ischemic stroke in a population-based cohort. J Am Coll Cardiol (2013) 1.52
Recurrent stroke predictors differ in medically treated patients with pathogenic vs. other PFOs. Neurology (2014) 1.49
The risk of paradoxical embolism (RoPE) study: initial description of the completed database. Int J Stroke (2012) 1.32
When and how to diagnose patent foramen ovale. Heart (2005) 1.26
Indications for the closure of patent foramen ovale. Heart (2004) 1.16
The brain's heart - therapeutic opportunities for patent foramen ovale (PFO) and neurovascular disease. Pharmacol Ther (2013) 1.07
Transcranial Doppler ultrasonography should it be the first choice for persistent foramen ovale screening? Cardiovasc Ultrasound (2014) 1.03
Systematic review of percutaneous closure versus medical therapy in patients with cryptogenic stroke and patent foramen ovale. BMJ Open (2014) 1.02
Factors related to recurrence of paradoxical cerebral embolism due to patent foramen ovale. J Neurol (2011) 1.01
Patent foramen ovale in cerebral infarction. Curr Cardiol Rev (2010) 0.97
Percutaneous closure of patent foramen ovale: a case series and literature review. Clin Med Res (2007) 0.97
Patent foramen ovale and stroke. J Cardiol (2010) 0.93
Transcatheter patent foramen ovale closure versus medical therapy for cryptogenic stroke: a meta-analysis of randomized clinical trials. BMC Cardiovasc Disord (2013) 0.92
A suspected case of paradoxical renal embolism through the patent foramen ovale. Clin Exp Nephrol (2010) 0.92
Contemporary approach to paradoxical embolism. Circulation (2014) 0.91
Secondary stroke prevention: patent foramen ovale, aortic plaque, and carotid stenosis. Eur Heart J (2012) 0.91
Antithrombotic medication for cardioembolic stroke prevention. Stroke Res Treat (2011) 0.87
Transesophageal echocardiography in patients with cryptogenic cerebral ischemia. Cardiovasc Ultrasound (2009) 0.86
Patent foramen ovale, cardiac valve thickening, and antiphospholipid antibodies as risk factors for subsequent vascular events: the PICSS-APASS study. Stroke (2009) 0.86
Prevention of cardioembolic stroke. Neurotherapeutics (2011) 0.85
Patent foramen ovale and the risk of stroke: smoking gun guilty by association? Heart (2005) 0.84
Rethinking trial strategies for stroke and patent foramen ovale. Curr Opin Neurol (2010) 0.84
Cerebral microembolism during transcatheter closure of patent foramen ovale. J Neurol (2004) 0.83
Anatomo-functional characterization of interatrial septum for catheter-based interventions. Am J Cardiovasc Dis (2011) 0.83
Percutaneous closure versus medical therapy alone for cryptogenic stroke patients with a patent foramen ovale: meta-analysis of randomized controlled trials. Tex Heart Inst J (2014) 0.83
Patent Foramen Ovale and Stroke-Current Status. J Stroke (2015) 0.83
Decrease in shunt volume in patients with cryptogenic stroke and patent foramen ovale. BMC Neurol (2010) 0.82
Anticoagulant vs. antiplatelet therapy in patients with cryptogenic stroke and patent foramen ovale: an individual participant data meta-analysis. Eur Heart J (2015) 0.82
Complications and mid-term outcome after percutaneous patent foramen ovale closure in patients with cryptogenic stroke. Neth Heart J (2008) 0.82
Multidisciplinary management of patent foramen ovale (PFO) and cryptogenic stroke/TIA. J Multidiscip Healthc (2013) 0.81
Patent foramen ovale and atrial septal aneurysm in cryptogenic stroke. Postgrad Med J (2007) 0.81
Learning on the Web. Case 2: patent foramen ovale (PFO) and paradoxical embolism. Heart (2003) 0.81
Decoding cryptogenic cardioembolism. Ann Neurol (2008) 0.81
The role of the sizing balloon in selection of the patent foramen ovale closure device size. Exp Clin Cardiol (2008) 0.81
Patent foramen ovale and recurrent stroke: another paradoxical twist. Circulation (2002) 0.81
Intermediate and long-term results of transcatheter closure of patent foramen ovale using the amplatzer patent foramen ovale occluder: one case of pulmonary embolism irrespective of patent foramen ovale closure. Korean Circ J (2011) 0.80
Atrial septal aneurysm mimicking a cor triatriatum sinister: a case report and review of the literature. Clin Med Insights Case Rep (2012) 0.79
Influence of transoesophageal echocardiography on therapy and prognosis in young patients with TIA or ischaemic stroke. Neth Heart J (2009) 0.79
Transcatheter Closure of Intracardiac Shunts. Curr Treat Options Cardiovasc Med (2004) 0.79
Sustained risk of recurrent thromboembolic events in patients with patent foramen ovale and paradoxical embolism: long-term follow-up over more than 15 years. Clin Res Cardiol (2011) 0.78
Determinants of antithrombotic choice for patent foramen ovale in cryptogenic stroke. Neurology (2014) 0.78
Embolic Strokes of Unknown Source and Cryptogenic Stroke: Implications in Clinical Practice. Front Neurol (2016) 0.78
Comparison of medical treatments in cryptogenic stroke patients with patent foramen ovale: A randomized clinical trial. J Res Med Sci (2013) 0.78
Role of cardiac and extracranial vascular CT in the evaluation/management of cerebral ischemia and stroke. Emerg Radiol (2013) 0.78
Evaluation of patent foramen ovale in young adults with cryptogenic stroke. ARYA Atheroscler (2011) 0.77
Risk and fate of residual interatrial shunting after transcatheter closure of patent foramen ovale: a long term follow up study. Eur J Med Res (2011) 0.77
Mean platelet volume is elevated in patients with patent foramen ovale. Arch Med Sci (2013) 0.77
Antiplatelet therapy in secondary stroke prevention--state of the art. J Cell Mol Med (2010) 0.76
Current issues in antiplatelet therapy for stroke prevention: the importance of stroke subtypes and differences between stroke and MI patients. J Neurol (2010) 0.76
Cardiological evaluation after cerebral ischaemia : Consensus statement of the Working Group Heart and Brain of the German Cardiac Society-Cardiovascular Research (DGK) and the German Stroke Society (DSG). Clin Res Cardiol (2010) 0.76
Lack of association between right-to-left shunt and cerebral ischemia after adjustment for gender and age. J Negat Results Biomed (2008) 0.76
Stroke and patent foramen ovale: intervene or wait. BMJ Case Rep (2015) 0.75
Cardioembolic Stroke. Circ Res (2017) 0.75
How to Understand Patent Foramen Ovale Clinical Significance - Part II: Therapeutic Strategies in Cryptogenic Stroke. J Cardiovasc Echogr (2017) 0.75
Should patent foramen ovale be closed in patients with recent cryptogenic stroke or presumptive platypnea-orthodeoxia syndrome? Tex Heart Inst J (2011) 0.75
Caring for the adult with congenital heart disease: management of common defects. Perm J (2007) 0.75
Potential new uses of non-vitamin K antagonist oral anticoagulants to treat and prevent stroke. Neurology (2015) 0.75
Transcranial Doppler ultrasonography: From methodology to major clinical applications. World J Cardiol (2016) 0.75
Searching for patent foramen ovale in a 44-year-old female patient after ischemic stroke - diagnostic problems. Kardiochir Torakochirurgia Pol (2016) 0.75
Non-cardioembolic Mechanisms in Cryptogenic Stroke: Clinical and Diffusion-weighted Imaging Features. J Clin Neurol (2005) 0.75
Modified Right Heart Contrast Echocardiography Versus Traditional Method in Diagnosis of Right-to-Left Shunt: A Comparative Study. Pol J Radiol (2016) 0.75
Cryptogenic stroke following abdominal free flap breast reconstruction surgery. Int J Surg Case Rep (2014) 0.75
Patent foramen ovale and cryptogenic stroke: the controversy continues. Circulation (2003) 0.75
Antithrombotic therapy in cardiac embolism. Curr Cardiol Rev (2010) 0.75
Paradoxical Embolism due to Persistent Foramen Ovale; a Case Report. Emerg (Tehran) (2017) 0.75
Patent foramen ovale as a preferential mechanism for increasing the likelihood of brain tumor metastasis. Am J Cardiovasc Dis (2011) 0.75
The Evolving Role and Use of Echocardiography in the Evaluation of Cardiac Source of Embolism. J Cardiovasc Echogr (2017) 0.75
Critical appraisal of medical devices in the management of cerebrovascular disease. Ther Clin Risk Manag (2008) 0.75
How to Understand Patent Foramen Ovale Clinical Significance: Part I. J Cardiovasc Echogr (2017) 0.75
Mid-term results of interventional closure of patent foramen ovale with the Occlutech Figulla(®) Flex II Occluder. BMC Cardiovasc Disord (2016) 0.75
Comparison of Outcomes after Device Closure and Medication Alone in Patients with Patent Foramen Ovale and Cryptogenic Stroke in Korean Population. Yonsei Med J (2016) 0.75
Silent cerebral emboli following percutaneous closure of atrial septal defect in pediatric patients: a diffusion-weighted MRI study. Diagn Interv Radiol (2015) 0.75
The Role of Patent Foramen Ovale in Cryptogenic Stroke. Noro Psikiyatr Ars (2016) 0.75
Transcranial Doppler Ultrasound: Incremental Diagnostic Role in Cryptogenic Stroke Part II. J Cardiovasc Echogr (2017) 0.75
Prevention of recurrent stroke in patients with patent foramen ovale. Neurol Clin (2015) 0.75
Investigation of association between PFO complicated by cryptogenic stroke and a common variant of the cardiac transcription factor GATA4. PLoS One (2011) 0.75
Antithrombotic and interventional treatment options in cardioembolic transient ischaemic attack and ischaemic stroke. J Neurol Neurosurg Psychiatry (2007) 0.75
Patent foramen ovale and stroke: what should be done? Curr Opin Hematol (2009) 0.75
Short-Term and Two-Year Rate of Recurrent Cerebrovascular Events in Patients with Acute Cerebral Ischemia of Undetermined Aetiology, with and without a Patent Foramen Ovale. ISRN Neurol (2011) 0.75
Transthoracic contrast echocardiography using vitamin B6 and sodium bicarbonate as contrast agents for the diagnosis of patent foramen ovale. Int J Cardiovasc Imaging (2017) 0.75
Prevalence and characteristics of right-to-left shunt in migraine with aura: a survey on 120 Italian patients. Neurol Sci (2009) 0.75
Patent foramen ovale and left atrial appendage: new devices and methods for closure. Pediatr Cardiol (2005) 0.75
Prevalence of patent foramen ovale in ischemic stroke in Italy: the SISIFO study. Neurol Sci (2014) 0.75
A case of pulmonary arteriovenous malformation: role of interventional radiology in diagnosis and treatment. Ann Transl Med (2017) 0.75
A Diagnostic Approach to Stroke in Young Adults. Curr Treat Options Cardiovasc Med (2017) 0.75
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 56.72
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 41.47
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 26.95
Stenting versus endarterectomy for treatment of carotid-artery stenosis. N Engl J Med (2010) 17.57
Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet (2010) 11.25
The state of US health, 1990-2010: burden of diseases, injuries, and risk factors. JAMA (2013) 10.43
Global and regional burden of stroke during 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet (2014) 10.06
2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol (2014) 9.96
Telmisartan to prevent recurrent stroke and cardiovascular events. N Engl J Med (2008) 7.25
Warfarin and aspirin in patients with heart failure and sinus rhythm. N Engl J Med (2012) 6.60
Transient ischemic attack--proposal for a new definition. N Engl J Med (2002) 4.94
Ischemic stroke subtype incidence among whites, blacks, and Hispanics: the Northern Manhattan Study. Circulation (2005) 4.08
Update to the AHA/ASA recommendations for the prevention of stroke in patients with stroke and transient ischemic attack. Stroke (2008) 4.06
An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2013) 3.60
Morning increase in onset of ischemic stroke. Stroke (1989) 3.52
Antiphospholipid antibodies and subsequent thrombo-occlusive events in patients with ischemic stroke. JAMA (2004) 3.51
Statin therapy in the prevention of recurrent cardiovascular events: a sex-based meta-analysis. Arch Intern Med (2012) 3.50
Predictors of hemorrhage in patients with untreated brain arteriovenous malformation. Neurology (2006) 3.46
Patent foramen ovale as a risk factor for cryptogenic stroke. Ann Intern Med (1992) 3.38
Periodontal microbiota and carotid intima-media thickness: the Oral Infections and Vascular Disease Epidemiology Study (INVEST). Circulation (2005) 3.25
Predicting long-term outcome after acute ischemic stroke: a simple index works in patients from controlled clinical trials. Stroke (2008) 3.21
The Harvard Cooperative Stroke Registry: a prospective registry. Neurology (1978) 3.19
Sodium, blood pressure, and cardiovascular disease: further evidence supporting the American Heart Association sodium reduction recommendations. Circulation (2012) 3.14
Infarcts of undetermined cause: the NINCDS Stroke Data Bank. Ann Neurol (1989) 3.13
The Stroke Data Bank: design, methods, and baseline characteristics. Stroke (1988) 3.12
The importance of population-wide sodium reduction as a means to prevent cardiovascular disease and stroke: a call to action from the American Heart Association. Circulation (2011) 2.89
National Stroke Association guidelines for the management of transient ischemic attacks. Ann Neurol (2006) 2.82
Should thrombolytic therapy be the first-line treatment for acute ischemic stroke? Thrombolysis--not a panacea for ischemic stroke. N Engl J Med (1997) 2.82
Forecasting the future of stroke in the United States: a policy statement from the American Heart Association and American Stroke Association. Stroke (2013) 2.66
Transesophageal echocardiography in cryptogenic stroke and patent foramen ovale: analysis of putative high-risk features from the risk of paradoxical embolism database. Circ Cardiovasc Imaging (2013) 2.56
Metabolic syndrome and ischemic stroke risk: Northern Manhattan Study. Stroke (2007) 2.55
Moderate alcohol consumption reduces risk of ischemic stroke: the Northern Manhattan Study. Stroke (2005) 2.51
Ideal cardiovascular health predicts lower risks of myocardial infarction, stroke, and vascular death across whites, blacks, and hispanics: the northern Manhattan study. Circulation (2012) 2.48
Relationship between periodontal disease, tooth loss, and carotid artery plaque: the Oral Infections and Vascular Disease Epidemiology Study (INVEST). Stroke (2003) 2.45
2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement. J Am Coll Cardiol (2012) 2.44
Broca aphasia: pathologic and clinical. Neurology (1978) 2.43
The New York Islands AVM Study: design, study progress, and initial results. Stroke (2003) 2.42
Aortic arch plaques and risk of recurrent stroke and death. Circulation (2009) 2.40
Comparison of 30-day mortality models for profiling hospital performance in acute ischemic stroke with vs without adjustment for stroke severity. JAMA (2012) 2.38
Stroke in the young in the northern Manhattan stroke study. Stroke (2002) 2.37
Patent foramen ovale and stroke. Circulation (2005) 2.34
Traditional risk factors are not major contributors to the variance in carotid intima-media thickness. Stroke (2013) 2.34
Relation of plasma glucose and endothelial function in a population-based multiethnic sample of subjects without diabetes mellitus. Am J Cardiol (2005) 2.34
Long-term functional recovery after first ischemic stroke: the Northern Manhattan Study. Stroke (2009) 2.33
Risk of myocardial infarction or vascular death after first ischemic stroke: the Northern Manhattan Study. Stroke (2007) 2.30
Central poststroke pain and Wallenberg's lateral medullary infarction: frequency, character, and determinants in 63 patients. Neurology (1997) 2.28
An index to identify stroke-related vs incidental patent foramen ovale in cryptogenic stroke. Neurology (2013) 2.26
Neurologic deterioration in noncomatose patients with supratentorial intracerebral hemorrhage. Neurology (1994) 2.21
Intracerebral hemorrhage: external validation and extension of a model for prediction of 30-day survival. Ann Neurol (1991) 2.20
Comparison of warfarin versus aspirin for the prevention of recurrent stroke or death: subgroup analyses from the Warfarin-Aspirin Recurrent Stroke Study. Cerebrovasc Dis (2006) 2.19
Left ventricular mass and geometry and the risk of ischemic stroke. Stroke (2003) 2.15
Patent foramen ovale and the risk of ischemic stroke in a multiethnic population. J Am Coll Cardiol (2007) 2.15
The natural history of CADASIL: a pooled analysis of previously published cases. Stroke (1999) 2.14
Infectious burden and risk of stroke: the northern Manhattan study. Arch Neurol (2009) 2.08
Direct measurement of multiple vena contracta areas for assessing the severity of mitral regurgitation using 3D TEE. JACC Cardiovasc Imaging (2012) 2.06
Antithrombotic and thrombolytic therapy for ischemic stroke: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest (2008) 2.06
Clinical outcome after first and recurrent hemorrhage in patients with untreated brain arteriovenous malformation. Stroke (2006) 2.05
Insulin resistance and risk of ischemic stroke among nondiabetic individuals from the northern Manhattan study. Arch Neurol (2010) 2.00
Reporting terminology for brain arteriovenous malformation clinical and radiographic features for use in clinical trials. Stroke (2001) 1.97
Chronic kidney disease is associated with white matter hyperintensity volume: the Northern Manhattan Study (NOMAS). Stroke (2007) 1.96
Prevalence and prognostic value of subclinical left ventricular systolic dysfunction by global longitudinal strain in a community-based cohort. Eur J Heart Fail (2014) 1.96
Tumor necrosis factor receptor levels are associated with carotid atherosclerosis. Stroke (2002) 1.94
Prediction of intracerebral hemorrhage survival. Ann Neurol (1988) 1.92
Behavioral studies of aphasia: methods of investigation and analysis. Neuropsychologia (1971) 1.92
Total homocysteine is associated with white matter hyperintensity volume: the Northern Manhattan Study. Stroke (2005) 1.91
Stroke location and association with fatal cardiac outcomes: Northern Manhattan Study (NOMAS). Stroke (2008) 1.91
Mediterranean-style diet and risk of ischemic stroke, myocardial infarction, and vascular death: the Northern Manhattan Study. Am J Clin Nutr (2011) 1.91
Our time: a call to save preventable death from cardiovascular disease (heart disease and stroke). Circulation (2012) 1.87
Aortic atherosclerosis, hypercoagulability, and stroke the APRIS (Aortic Plaque and Risk of Ischemic Stroke) study. J Am Coll Cardiol (2008) 1.85
Ventriculostomy-related infections: a critical review of the literature. Neurosurgery (2002) 1.84